UnicoCell Biomed Co (TPE:6794) FCF Margin % : -172.86% (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is UnicoCell Biomed Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. UnicoCell Biomed Co's Free Cash Flow for the three months ended in Dec. 2024 was NT$-18.72 Mil. UnicoCell Biomed Co's Revenue for the three months ended in Dec. 2024 was NT$10.83 Mil. Therefore, UnicoCell Biomed Co's FCF Margin % for the quarter that ended in Dec. 2024 was -172.86%.

As of today, UnicoCell Biomed Co's current FCF Yield % is -1.65%.

The historical rank and industry rank for UnicoCell Biomed Co's FCF Margin % or its related term are showing as below:

TPE:6794' s FCF Margin % Range Over the Past 10 Years
Min: -3742.01 Med: -776.38 Max: -210.86
Current: -210.86

During the past 8 years, the highest FCF Margin % of UnicoCell Biomed Co was -210.86%. The lowest was -3742.01%. And the median was -776.38%.

TPE:6794's FCF Margin % is ranked worse than
56.53% of 1019 companies
in the Biotechnology industry
Industry Median: -144.89 vs TPE:6794: -210.86

UnicoCell Biomed Co FCF Margin % Historical Data

The historical data trend for UnicoCell Biomed Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

UnicoCell Biomed Co FCF Margin % Chart

UnicoCell Biomed Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

-3,742.01

-1,048.09

-543.24

-331.56

-210.86

UnicoCell Biomed Co Quarterly Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial													-251.25	-749.53	-435.58	-84.32	-172.86

Competitive Comparison of UnicoCell Biomed Co's FCF Margin %

For the Biotechnology subindustry, UnicoCell Biomed Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

UnicoCell Biomed Co's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, UnicoCell Biomed Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where UnicoCell Biomed Co's FCF Margin % falls into.

Save Embed

UnicoCell Biomed Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

UnicoCell Biomed Co's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-67.224	/	31.881
	=	-210.86 %

UnicoCell Biomed Co's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-18.724	/	10.832
	=	-172.86 %

UnicoCell Biomed Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of UnicoCell Biomed Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

UnicoCell Biomed Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » UnicoCell Biomed Co Ltd (TPE:6794) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Minquan East Road, 5th Floor, No. 13-20, Section 6, Neihu District, Taipei, TWN, 11494

Website

https://www.unicocell.com

UnicoCell Biomed Co Ltd is a biotechnology company. Its main business includes new drug R&D and human tissue-derived stem cell inspection and testing, extraction, storage, and technology R&D.

UnicoCell Biomed Co Headlines

No Headlines